ArticleCureus2025
Resulting Sequelae of an Immunosuppressive State in a Pediatric Patient Status Post Bone Marrow Transplant for the Curative Management of Myelodysplastic Syndrome.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Myelodysplastic syndrome is a clonal disorder of hematopoietic stem cells leading to dysplasia and ineffective hematopoiesis. The typical presentation is asymptomatic with incidental lab findings consistent with varying degrees of pancytopenia. This syndrome is commonly diagnosed in older individuals and tends to result from chemical and/or radiation exposures; however, this patient presents as a unique manifestation of myelodysplastic syndrome in a six-month-old male. For curative management, the patient had an initial haploidentical hematopoietic stem cell transplant, followed by another, due to early graft rejection. In the following years leading to the present time, the patient has had complications due to a persistent immunodeficient state. He has been evaluated and managed for seizures, anemia, chemotherapy-induced cardiomyopathy, hypogammaglobinemia, failure to thrive, recurrent infections, graft versus host disease, malnutrition, and hypertransaminasemia with hepatosplenomegaly. He has had resolution of his cardiomyopathy and seizures but continues to manage his persistent immunodeficiencies, hepatomegaly, and slow weight gain. It is hard to discern if the multitude of dysfunctions arises from pharmacologically induced immunodeficiency, from parental and environmental neglect, if the manifestations compounded one another, or if the above factors combined to create the unique constellation of clinical manifestations. This patient provides insight into the complexities associated with understanding unique manifestations in dysplastic and oncological conditions, as well as managing complications arising from treatment. This case raises awareness of medical complications in the context of parental neglect and the importance of managing them both. The authors received consent from the patient's guardian to use their data for this report.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.